Winning Health Technology Group Future Growth
Future criteria checks 4/6
Winning Health Technology Group is forecast to grow earnings and revenue by 25.6% and 16.2% per annum respectively. EPS is expected to grow by 25.6% per annum. Return on equity is forecast to be 10.4% in 3 years.
Key information
25.6%
Earnings growth rate
25.6%
EPS growth rate
| Healthcare Services earnings growth | 28.8% |
| Revenue growth rate | 16.2% |
| Future return on equity | 10.4% |
| Analyst coverage | Good |
| Last updated | 21 May 2024 |
Recent future growth updates
Recent updates
Impressive Earnings May Not Tell The Whole Story For Winning Health Technology Group (SZSE:300253)
May 03
Is Winning Health Technology Group (SZSE:300253) A Risky Investment?
Mar 19Winning Health Technology Group Co., Ltd. (SZSE:300253) Held Back By Insufficient Growth Even After Shares Climb 25%
Mar 01Returns On Capital At Winning Health Technology Group (SZSE:300253) Paint A Concerning Picture
Feb 28Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 4,986 | 906 | N/A | 694 | 7 |
| 12/31/2025 | 4,406 | 708 | N/A | 539 | 8 |
| 12/31/2024 | 3,654 | 560 | N/A | 627 | 8 |
| 3/31/2024 | 3,209 | 438 | -134 | 168 | N/A |
| 12/31/2023 | 3,163 | 358 | -129 | 185 | N/A |
| 9/30/2023 | 3,123 | 121 | -253 | 82 | N/A |
| 6/30/2023 | 3,189 | 58 | -296 | 24 | N/A |
| 3/31/2023 | 3,097 | 13 | -234 | 107 | N/A |
| 1/1/2023 | 3,093 | 109 | -223 | 100 | N/A |
| 9/30/2022 | 2,858 | 258 | 54 | 379 | N/A |
| 6/30/2022 | 2,822 | 333 | 143 | 461 | N/A |
| 3/31/2022 | 2,851 | 396 | 171 | 468 | N/A |
| 1/1/2022 | 2,750 | 378 | 82 | 368 | N/A |
| 9/30/2021 | 2,658 | 547 | 106 | 332 | N/A |
| 6/30/2021 | 2,498 | 528 | 112 | 312 | N/A |
| 3/31/2021 | 2,333 | 494 | 212 | 406 | N/A |
| 12/31/2020 | 2,267 | 491 | 203 | 390 | N/A |
| 9/30/2020 | 2,082 | 329 | 81 | 270 | N/A |
| 6/30/2020 | 2,032 | 311 | -4 | 213 | N/A |
| 3/31/2020 | 1,939 | 353 | 13 | 213 | N/A |
| 12/31/2019 | 1,908 | 398 | 42 | 233 | N/A |
| 9/30/2019 | 1,712 | 384 | -61 | 117 | N/A |
| 6/30/2019 | 1,561 | 347 | 30 | 194 | N/A |
| 3/31/2019 | 1,480 | 320 | -6 | 161 | N/A |
| 12/31/2018 | 1,439 | 303 | -43 | 124 | N/A |
| 9/30/2018 | 1,439 | 288 | -93 | 91 | N/A |
| 6/30/2018 | 1,330 | 259 | -136 | 27 | N/A |
| 3/31/2018 | 1,242 | 243 | -190 | -22 | N/A |
| 12/31/2017 | 1,204 | 229 | N/A | 80 | N/A |
| 9/30/2017 | 1,059 | 193 | N/A | -57 | N/A |
| 6/30/2017 | 1,011 | 184 | N/A | -26 | N/A |
| 3/31/2017 | 987 | 523 | N/A | 121 | N/A |
| 12/31/2016 | 954 | 519 | N/A | 140 | N/A |
| 9/30/2016 | 901 | 522 | N/A | 158 | N/A |
| 6/30/2016 | 852 | 517 | N/A | 101 | N/A |
| 3/31/2016 | 791 | 158 | N/A | 26 | N/A |
| 12/31/2015 | 753 | 153 | N/A | 79 | N/A |
| 9/30/2015 | 647 | 142 | N/A | -48 | N/A |
| 6/30/2015 | 607 | 142 | N/A | 8 | N/A |
| 3/31/2015 | 536 | 127 | N/A | 22 | N/A |
| 12/31/2014 | 491 | 121 | N/A | 43 | N/A |
| 9/30/2014 | 402 | 100 | N/A | 62 | N/A |
| 6/30/2014 | 374 | 91 | N/A | 41 | N/A |
| 3/31/2014 | 358 | 84 | N/A | 47 | N/A |
| 12/31/2013 | 349 | 81 | N/A | 50 | N/A |
| 9/30/2013 | 325 | 68 | N/A | 50 | N/A |
| 6/30/2013 | 297 | 61 | N/A | 26 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 300253's forecast earnings growth (25.6% per year) is above the savings rate (2.9%).
Earnings vs Market: 300253's earnings (25.6% per year) are forecast to grow faster than the CN market (22.2% per year).
High Growth Earnings: 300253's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 300253's revenue (16.2% per year) is forecast to grow faster than the CN market (13.7% per year).
High Growth Revenue: 300253's revenue (16.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 300253's Return on Equity is forecast to be low in 3 years time (10.4%).